Adalimumab for rheumatoid arthritis: a patient guide

This medicine belongs to a group called tumour necrosis factor inhibitors. It is injected under the skin and may be prescribed alone or with another disease-modifying medicine. The rheumatology team selects treatment according to disease activity, previous medicines, other health conditions and personal circumstances.

Rheumatoid arthritis commonly presents with painful, swollen and stiff joints, often including the hands, and stiffness can be more noticeable after rest. Adalimumab is intended to suppress the inflammation behind these problems rather than simply mask pain. The team may assess symptoms, joint findings, function and blood tests when deciding whether it is helping.

Lowering immune activity can make infections harder to fight. Screening before the first dose may include checks for tuberculosis and hepatitis, while later appointments may include blood monitoring. Share any history of repeated infection, nerve symptoms, heart problems, cancer treatment or allergic reactions before starting. Discuss pregnancy, breastfeeding and planned vaccines as well.

Use the injection exactly as demonstrated and keep it within the storage conditions on its label. Choose a different suitable injection area each time and examine the solution and device as instructed. If a device is damaged, the medicine looks unusual or a dose is forgotten, seek advice from the pharmacy or rheumatology service instead of improvising.

Attend monitoring appointments even when symptoms are settled. Record infections, new medicines and troublesome reactions so the prescriber can review them accurately. Gentle activity can help maintain joint motion and muscle capacity; adjust exercise during a flare according to pain, swelling and professional advice.

Get prompt medical advice for fever, chills, a cough that persists, shortness of breath, burning when passing urine, spreading skin redness, an infected wound or exposure to a significant contagious illness. Also report unexplained bruising, unusual paleness, marked weakness, numbness, new visual disturbance or swelling of the ankles.

Call emergency services if breathing becomes difficult, the lips or throat swell, you collapse, or severe symptoms develop soon after an injection. A painful widespread rash, blistering skin, sudden one-sided weakness or severe chest discomfort also needs emergency assessment.

Ask how the team will judge response, what monitoring schedule applies to you, and which infection symptoms should lead you to hold a dose and call. Confirm how to transport the injection, dispose of used devices, manage a missed dose, coordinate vaccines and prepare for any planned operation.